Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CD1D Biologics Sequence Review Report 2026: Antigen-presenting glycoprotein CD1d Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD1C Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1c Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD1B Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1b Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD1B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD177 Biologics Sequence Review Report 2026: CD177 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD177 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD151 Biologics Sequence Review Report 2026: CD151 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD14 Biologics Sequence Review Report 2026: Monocyte differentiation antigen CD14 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL28 Biologics Sequence Review Report 2026: C-C motif chemokine 28 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL27 Biologics Sequence Review Report 2026: C-C motif chemokine 27 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL23 Biologics Sequence Review Report 2026: C-C motif chemokine 23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL23 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL15 Biologics Sequence Review Report 2026: C-C motif chemokine 15 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFBRAP1 Biologics Sequence Review Report 2026: Transforming growth factor-beta receptor-associated protein 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBRAP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFBR3 Biologics Sequence Review Report 2026: Transforming growth factor beta receptor type 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
92
93
94
95
96
>>
1503
>